Clinical trial
Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse…
NCT00001826 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001826 |
|---|---|
| Title | Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor |
| Official title | A Long-Term Observational Study of Immunologic Reconstitution in HIV-1 Infected Children Who Are Receiving Combination Protease Inhibitor and Reverse Transcriptase Inhibitors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infection |
| Enrollment | 50 |
| Start date | Jul 1, 1999 |
| Completion | May 1, 2006 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: